BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25150256)

  • 1. Identification of minor histocompatibility antigens based on the 1000 Genomes Project.
    Oostvogels R; Lokhorst HM; Minnema MC; van Elk M; van den Oudenalder K; Spierings E; Mutis T; Spaapen RM
    Haematologica; 2014 Dec; 99(12):1854-9. PubMed ID: 25150256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens.
    Fuchs KJ; van de Meent M; Honders MW; Khatri I; Kester MGD; Koster EAS; Koutsoumpli G; de Ru AH; van Bergen CAM; van Veelen PA; 't Hoen PAC; van Balen P; van den Akker EB; Veelken JH; Halkes CJM; Falkenburg JHF; Griffioen M
    Blood; 2024 May; 143(18):1856-1872. PubMed ID: 38427583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized Whole Genome Association Scanning for Discovery of HLA Class I-Restricted Minor Histocompatibility Antigens.
    Fuchs KJ; Honders MW; van der Meijden ED; Adriaans AE; van der Lee DI; Pont MJ; Monajemi R; Kielbasa SM; 't Hoen PAC; van Bergen CAM; Falkenburg JHF; Griffioen M
    Front Immunol; 2020; 11():659. PubMed ID: 32362897
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Bykova NA; Malko DB; Efimov GA
    Front Immunol; 2018; 9():1819. PubMed ID: 30166983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of 4 novel HLA-B*40:01 restricted minor histocompatibility antigens and their potential as targets for graft-versus-leukemia reactivity.
    Griffioen M; Honders MW; van der Meijden ED; van Luxemburg-Heijs SA; Lurvink EG; Kester MG; van Bergen CA; Falkenburg JH
    Haematologica; 2012 Aug; 97(8):1196-204. PubMed ID: 22419570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid Multiplex Genotyping of 20 HLA-A
    Romaniuk DS; Postovskaya AM; Khmelevskaya AA; Malko DB; Efimov GA
    Front Immunol; 2019; 10():1226. PubMed ID: 31275297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput characterization of 10 new minor histocompatibility antigens by whole genome association scanning.
    Van Bergen CA; Rutten CE; Van Der Meijden ED; Van Luxemburg-Heijs SA; Lurvink EG; Houwing-Duistermaat JJ; Kester MG; Mulder A; Willemze R; Falkenburg JH; Griffioen M
    Cancer Res; 2010 Nov; 70(22):9073-83. PubMed ID: 21062987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minor histocompatibility antigens as targets of graft-versus-leukemia reactions.
    Falkenburg JH; Marijt WA; Heemskerk MH; Willemze R
    Curr Opin Hematol; 2002 Nov; 9(6):497-502. PubMed ID: 12394171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degree of predicted minor histocompatibility antigen mismatch correlates with poorer clinical outcomes in nonmyeloablative allogeneic hematopoietic cell transplantation.
    Larsen ME; Kornblit B; Larsen MV; Masmas TN; Nielsen M; Thiim M; Garred P; Stryhn A; Lund O; Buus S; Vindelov L
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1370-81. PubMed ID: 20353833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Modification of Cytotoxic Lymphocytes with T Cell Receptor Specific for Minor Histocompatibility Antigen ACC-1Y].
    Pilunov AM; Kuchmiy AA; Sheetikov SA; Filkin SY; Romaniuk DS; Rosov FN; Efimov GA
    Mol Biol (Mosk); 2019; 53(3):456-466. PubMed ID: 31184611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for the identification of T cell-recognized tumor antigens in hematological malignancies for improved graft-versus-tumor responses after allogeneic blood and marrow transplantation.
    Zilberberg J; Feinman R; Korngold R
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1000-7. PubMed ID: 25459643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions.
    Akatsuka Y; Morishima Y; Kuzushima K; Kodera Y; Takahashi T
    Cancer Sci; 2007 Aug; 98(8):1139-46. PubMed ID: 17521316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refinement of molecular approaches to improve the chance of identification of hematopoietic-restricted minor histocompatibility antigens.
    de Rijke B; van Horssen-Zoetbrood A; Veenbergen S; Fredrix H; de Witte T; van de Wiel-van Kemenade E; Dolstra H
    J Immunol Methods; 2008 Jan; 329(1-2):125-37. PubMed ID: 17996247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution.
    Warren EH; Greenberg PD; Riddell SR
    Blood; 1998 Mar; 91(6):2197-207. PubMed ID: 9490709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and Differential Processing of HLA Class II-Restricted Minor Histocompatibility Antigen LB-PIP4K2A-1S and Its Allelic Variant by Asparagine Endopeptidase.
    Kremer AN; Bausenwein J; Lurvink E; Kremer AE; Rutten CE; van Bergen CAM; Kretschmann S; van der Meijden E; Honders MW; Mazzeo D; Watts C; Mackensen A; Falkenburg JHF; Griffioen M
    Front Immunol; 2020; 11():381. PubMed ID: 32218783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minor histocompatibility antigens: allo target molecules for tumor-specific immunotherapy.
    Goulmy E
    Cancer J; 2004; 10(1):1-7. PubMed ID: 15000488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of human minor histocompatibility antigens based on genetic association with highly parallel genotyping of pooled DNA.
    Kawase T; Nannya Y; Torikai H; Yamamoto G; Onizuka M; Morishima S; Tsujimura K; Miyamura K; Kodera Y; Morishima Y; Takahashi T; Kuzushima K; Ogawa S; Akatsuka Y
    Blood; 2008 Mar; 111(6):3286-94. PubMed ID: 18178869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopes.
    Ofran Y; Kim HT; Brusic V; Blake L; Mandrell M; Wu CJ; Sarantopoulos S; Bellucci R; Keskin DB; Soiffer RJ; Antin JH; Ritz J
    Clin Cancer Res; 2010 Mar; 16(5):1642-51. PubMed ID: 20160060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD31 mismatching affects marrow transplantation outcome.
    Grumet FC; Hiraki DD; Brown BWM ; Zehnder JL; Zacks ES; Draksharapu A; Parnes J; Negrin RS
    Biol Blood Marrow Transplant; 2001; 7(9):503-12. PubMed ID: 11669217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of MHC II-restricted minor histocompatibility antigens after HLA-identical stem-cell transplantation.
    Milosevic S; Bachnick B; Karim K; Bornkamm GW; Witter K; Gerbitz A; Mautner J; Behrends U
    Transplantation; 2010 Nov; 90(9):1030-5. PubMed ID: 20802400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.